Stroke in Young Military Men With Heterozygous for MTHFR Gene Mutation or Factor V Leiden Gene Mutation Associated With Patent Foramen Ovale: Report of Two Cases and Therapeutic Strategy.
Rodrigo Tavares BrissonJosevânia Fulgêncio de Lima ArrudaLiene Duarte SilvaDilermando Leal Júnio de JesusViviane de Hiroki Flumignan ZetolaMarcia Aparecida Camacho Kauffmann NogueiraPublished in: Military medicine (2021)
We report two cases of Brazilian patients (a 22-year-old male and a 48-year-old male) with ischemic stroke, whose arterial vascular study and echocardiographic investigation did not reveal any steno-occlusive arterial disease or typical cardioembolic finding, such as atrial fibrillation or myocardial dysfunction. A transcranial Doppler ultrasound and a transesophageal echocardiogram showed a patent foramen ovale (PFO), and the laboratory screening for coagulation abnormalities showed heterozygosity for MTHFR C677T and A1298C in one of the patients and heterozygosity for factor V Leiden gene mutations in the other patient. The significance of the association of PFO with Methylenetetrahydrofolate (MTHFR) C677T and A1298C variants or factor V Leiden mutation is discussed as a possible cause of ischemic stroke through paradoxical embolism from a venous source. There is a high prevalence of these two mentioned conditions in the general population, so we discuss two cases in which indication for anticoagulant therapy or percutaneous closure of PFO prevails.
Keyphrases
- atrial fibrillation
- end stage renal disease
- ejection fraction
- newly diagnosed
- left ventricular
- heart failure
- left atrial
- prognostic factors
- peritoneal dialysis
- chronic kidney disease
- left atrial appendage
- minimally invasive
- patient reported outcomes
- percutaneous coronary intervention
- catheter ablation
- case report
- dna methylation
- coronary artery disease
- oxidative stress
- gene expression
- pulmonary hypertension
- acute coronary syndrome
- patient reported
- blood brain barrier
- smoking cessation